Buy article online - an online subscription or single-article purchase is required to access this article.
Download citation
Download citation
link to html
In the square-planar title complex, [PtI2(C7H7NO)2], the Pt atom lies on a crystallographic inversion center, coinciding with an anti arrangement of the 3-acetyl­pyridine ligands. The dihedral angles between the pyridine rings and the Pt coordination plane are 67.5 (2)°, while those between the pyridine rings and the acetyl planes are 20.8 (5)°. The 195Pt NMR resonance of the title complex (CD2Cl2) was observed at −3224 p.p.m. The major structural parameters are compared with those from previously reported related structures.

Supporting information

cif

Crystallographic Information File (CIF) https://doi.org/10.1107/S0108270106045197/fa3046sup1.cif
Contains datablocks I, global

hkl

Structure factor file (CIF format) https://doi.org/10.1107/S0108270106045197/fa3046Isup2.hkl
Contains datablock I

pdf

Portable Document Format (PDF) file https://doi.org/10.1107/S0108270106045197/fa3046sup3.pdf
Supplementary material

CCDC reference: 632931

Comment top

The anticancer drug cisplatin, cis-Pt(NH3)2Cl2, and a few other platinum agents are widely used in the clinical treatment of testicular, ovarian, bladder, head and neck tumors (Farrell, 1989; O'Dwyer et al., 1999). Structure–activity rules that emerged from early studies include the assessment that trans complexes are therapeutically inactive, as opposed to cis complexes – a rule based mainly on the lack of activity for transplatin. Some exceptions from this paradigm were found in 1989, including trans-Pt(pyridine)2Cl2 (Farrell et al., 1989), which is even active towards leukemia L1210 cisplatin-resistant cell lines (Van Beusichem & Farrell, 1992). A review of the cytotoxicity of trans-platinum complexes has been published recently (Natile & Coluccia, 2001).

Platinum–pyridine derivative compounds not only gained interest because of this rule-breaking finding, but also due to the recently reported anticancer complex cis-PtCl2(NH3)(2-picoline) (AMD473) (Chen et al., 1998; Holford et al., 1998). This compound, active both via oral administration and injection, is currently in phase II clinical trials. Other than AMD473 itself and its trans-isomer (McGowan et al., 2005), recent studies involving platinum complexes containing pyridine derivatives (Ypy) include Pt(ESDT)(Ypy)(NH3)Cl (Marzano et al., 2002, 2004; Giovagnini et al., 2005), in which the ethylsarcosinedithiocarbamate ligand (ESDT) is used to reduce nephrotoxic effects, Pt(OAc)2(Ypy)2 and Pt(OAc)2(Ypy)(NH3) (Ma et al., 2005; Quiroga et al., 2006), in which the acetate ligands were used in order to obtain water-soluble complexes, and trans-PtCl2(4-pic)L (Najajreh et al., 2005), where L is a nonplanar heterocyclic amine ligand. The cytotoxicity of this last compound is improved compared to transplatin (Khazanov et al., 2002; Najajreh et al., 2003), but the non-activity of trans-Pt(NH3)Cl2(hmpy), trans-Pt(hmpy)2Cl2 and [Pt(hmpy)3Cl]Cl (hmpy is 3- or 4-hydroxymethylpyridine) precludes any generalization.

A few years ago, we undertook a systematic and detailed study of complexes of the type cis- and trans-Pt(Ypy)2X2 (X is Cl-, I- or NO3-) (Tessier & Rochon, 1999, 2001) and their hydrolysis products (Rochon & Tessier, 2002) by various techniques, including multinuclear NMR and X-ray crystallography. The pyridine derivatives included pyridine, the three picoline isomers, 2,4-lutidine and 3,5-lutidine. This series was used to study the steric and ligand basicity effects on the nature of the Pt—Ypy bond, as well as the number of hydrolyzed species in neutral media. As expected, the steric effects preclude formation of hydroxy-bridged oligomers (Rochon & Tessier, 2002). We also observed a relation of the NMR chemical shifts with the pKa of the protonated ligands, indicating that the σ(YpyPt) bond is more important than the π(PtYpy) back-donation. We established the relative position of the ligands in the trans-influence series. In the course of the study, we obtained the title compound, (I), during an attempt to synthesize its cis-isomer. Compound (I) is the first example of an acetylpyridine–platinum complex to be structurally characterized.

Complex (I) is the trans-isomer. cistrans isomerization in Pt(Ypy)2X2 complexes is not uncommon (Kong & Rochon, 1978; Tessier & Rochon, 1999). The Pt atom lies on a crystallographic inversion center, resulting in an anti arrangement of the 3-acetylpyridine ligands. Table 1 lists the geometric parameters. The Pt—N and Pt—I bond distances are identical to those obtained for other trans-Pt(Ypy)2I2 complexes (Table 2). The bond angles and the coplanarity of the atoms indicate a square-planar geometry around the Pt center. The O atom in the acetyl group does not participate in any hydrogen bonding or long-range contact. The dihedral angle between the pyridine ring and the Pt coordination plane is 67.5 (2)°.

Table 2 lists the dihedral angles for previously reported trans-Pt(Ypy)2I2 complexes, while a more complete list for all square-planar complexes containing the trans-Pt(Ypy)2 moiety, as listed in the Cambridge Structural Database, (CSD, Version 5.27; Allen, 2002), is provided in the supplementary material (Table S1). The value obtained for compound (I) lies between the values obtained for the 3-methylpyridine (63.5°; KARVAA; Tessier & Rochon, 1999) and (3-pyridyl)methane-sulfonamide (69.1°; ACAZOU; Dodoff et al., 2004) complexes (Table 2). Various factors, such as steric hindrance, the other ligands and intermolecular interactions, could influence the orientation of the pyridine rings. As a general rule, ortho-substituted pyridine derivatives are almost perpendicular to the Pt coordination plane [for example, trans-Pt(2-Mepy)2I2 in Table 2]. The other ligands also seem to influence the dihedral angles. The order is as follows (from greater to smaller): I > Cl ~NH3 ~ C C > NO3. The values obtained for the nitrate complexes are noticeably smaller (39–40°; Tessier & Rochon, 2001).

The acetate moiety of (I) is not coplanar with the pyridine ring, as indicated by the dihedral angle of 20.8 (2)° (or see torsion angles in Table 1). This phenomenon is not uncommon for other platinum structures found in the CSD that contain at least one RC(O)-pyridine derivative (Table 3). The first five structures in Table 3 are monosubstituted on the pyridine derivative, the four following are disubstituted and the rest are tetrasubstituted. No general rule can be found, except that values seem to be smaller for monosubstituted complexes. The hydrogen-bonding pattern certainly plays an important role, as it occurs to some extent in all complexes in Table 3, with the exception of trans-Pt(4-(COOEt)py)2Cl2, where the ethoxycarbonyl moiety is almost coplanar with the pyridine ring (1.2°; Camalli et al., 1980). No hydrogen-bonding pattern is observed in (I).

The 195Pt NMR resonance of compound (I) was observed at -3224 p.p.m. This observation is in the expected range for trans-Pt(Ypy)2I2 complexes (-3122 to -3264 p.p.m.; Tessier & Rochon, 1999). The reaction of compound (I) with silver nitrate in acetone (Souchard et al., 1990; Tessier & Rochon, 2001) results in the formation of the trans-Pt(3-Acpy)2(NO3)2 species, as indicated by the 195Pt NMR signal (CDCl3) observed at -1474 p.p.m. The expected values for trans-Pt(Ypy)2(NO3)2 are from -1402 to -1481 p.p.m. (Tessier & Rochon, 2001).

Experimental top

Compound (I) was prepared by the published procedure for cis-Pt(amine)2I2 complexes (Souchard et al., 1990) using 3-acetylpyridine as a ligand [yield 75%; m.p. (decomposition) 523–528 K]. Yellow crystals suitable for X-ray crystallography were obtained by recrystallization from dichloromethane.

Refinement top

The structure was solved by direct methods with SHELXS97 (Sheldrick, 1997) and refined against all data by full-matrix least-squares techniques on F2 using SHELXL97 (Sheldrick, 1997). All non-H atoms were refined anisotropically. H atoms were placed in idealized positions on C atoms, with C—H = 0.93 and 0.96 Å for aromatic and methyl H atoms, respectively. PLATON (Spek, 2003) was used to check missing symmetry or voids in the structure. None was found.

Structure description top

The anticancer drug cisplatin, cis-Pt(NH3)2Cl2, and a few other platinum agents are widely used in the clinical treatment of testicular, ovarian, bladder, head and neck tumors (Farrell, 1989; O'Dwyer et al., 1999). Structure–activity rules that emerged from early studies include the assessment that trans complexes are therapeutically inactive, as opposed to cis complexes – a rule based mainly on the lack of activity for transplatin. Some exceptions from this paradigm were found in 1989, including trans-Pt(pyridine)2Cl2 (Farrell et al., 1989), which is even active towards leukemia L1210 cisplatin-resistant cell lines (Van Beusichem & Farrell, 1992). A review of the cytotoxicity of trans-platinum complexes has been published recently (Natile & Coluccia, 2001).

Platinum–pyridine derivative compounds not only gained interest because of this rule-breaking finding, but also due to the recently reported anticancer complex cis-PtCl2(NH3)(2-picoline) (AMD473) (Chen et al., 1998; Holford et al., 1998). This compound, active both via oral administration and injection, is currently in phase II clinical trials. Other than AMD473 itself and its trans-isomer (McGowan et al., 2005), recent studies involving platinum complexes containing pyridine derivatives (Ypy) include Pt(ESDT)(Ypy)(NH3)Cl (Marzano et al., 2002, 2004; Giovagnini et al., 2005), in which the ethylsarcosinedithiocarbamate ligand (ESDT) is used to reduce nephrotoxic effects, Pt(OAc)2(Ypy)2 and Pt(OAc)2(Ypy)(NH3) (Ma et al., 2005; Quiroga et al., 2006), in which the acetate ligands were used in order to obtain water-soluble complexes, and trans-PtCl2(4-pic)L (Najajreh et al., 2005), where L is a nonplanar heterocyclic amine ligand. The cytotoxicity of this last compound is improved compared to transplatin (Khazanov et al., 2002; Najajreh et al., 2003), but the non-activity of trans-Pt(NH3)Cl2(hmpy), trans-Pt(hmpy)2Cl2 and [Pt(hmpy)3Cl]Cl (hmpy is 3- or 4-hydroxymethylpyridine) precludes any generalization.

A few years ago, we undertook a systematic and detailed study of complexes of the type cis- and trans-Pt(Ypy)2X2 (X is Cl-, I- or NO3-) (Tessier & Rochon, 1999, 2001) and their hydrolysis products (Rochon & Tessier, 2002) by various techniques, including multinuclear NMR and X-ray crystallography. The pyridine derivatives included pyridine, the three picoline isomers, 2,4-lutidine and 3,5-lutidine. This series was used to study the steric and ligand basicity effects on the nature of the Pt—Ypy bond, as well as the number of hydrolyzed species in neutral media. As expected, the steric effects preclude formation of hydroxy-bridged oligomers (Rochon & Tessier, 2002). We also observed a relation of the NMR chemical shifts with the pKa of the protonated ligands, indicating that the σ(YpyPt) bond is more important than the π(PtYpy) back-donation. We established the relative position of the ligands in the trans-influence series. In the course of the study, we obtained the title compound, (I), during an attempt to synthesize its cis-isomer. Compound (I) is the first example of an acetylpyridine–platinum complex to be structurally characterized.

Complex (I) is the trans-isomer. cistrans isomerization in Pt(Ypy)2X2 complexes is not uncommon (Kong & Rochon, 1978; Tessier & Rochon, 1999). The Pt atom lies on a crystallographic inversion center, resulting in an anti arrangement of the 3-acetylpyridine ligands. Table 1 lists the geometric parameters. The Pt—N and Pt—I bond distances are identical to those obtained for other trans-Pt(Ypy)2I2 complexes (Table 2). The bond angles and the coplanarity of the atoms indicate a square-planar geometry around the Pt center. The O atom in the acetyl group does not participate in any hydrogen bonding or long-range contact. The dihedral angle between the pyridine ring and the Pt coordination plane is 67.5 (2)°.

Table 2 lists the dihedral angles for previously reported trans-Pt(Ypy)2I2 complexes, while a more complete list for all square-planar complexes containing the trans-Pt(Ypy)2 moiety, as listed in the Cambridge Structural Database, (CSD, Version 5.27; Allen, 2002), is provided in the supplementary material (Table S1). The value obtained for compound (I) lies between the values obtained for the 3-methylpyridine (63.5°; KARVAA; Tessier & Rochon, 1999) and (3-pyridyl)methane-sulfonamide (69.1°; ACAZOU; Dodoff et al., 2004) complexes (Table 2). Various factors, such as steric hindrance, the other ligands and intermolecular interactions, could influence the orientation of the pyridine rings. As a general rule, ortho-substituted pyridine derivatives are almost perpendicular to the Pt coordination plane [for example, trans-Pt(2-Mepy)2I2 in Table 2]. The other ligands also seem to influence the dihedral angles. The order is as follows (from greater to smaller): I > Cl ~NH3 ~ C C > NO3. The values obtained for the nitrate complexes are noticeably smaller (39–40°; Tessier & Rochon, 2001).

The acetate moiety of (I) is not coplanar with the pyridine ring, as indicated by the dihedral angle of 20.8 (2)° (or see torsion angles in Table 1). This phenomenon is not uncommon for other platinum structures found in the CSD that contain at least one RC(O)-pyridine derivative (Table 3). The first five structures in Table 3 are monosubstituted on the pyridine derivative, the four following are disubstituted and the rest are tetrasubstituted. No general rule can be found, except that values seem to be smaller for monosubstituted complexes. The hydrogen-bonding pattern certainly plays an important role, as it occurs to some extent in all complexes in Table 3, with the exception of trans-Pt(4-(COOEt)py)2Cl2, where the ethoxycarbonyl moiety is almost coplanar with the pyridine ring (1.2°; Camalli et al., 1980). No hydrogen-bonding pattern is observed in (I).

The 195Pt NMR resonance of compound (I) was observed at -3224 p.p.m. This observation is in the expected range for trans-Pt(Ypy)2I2 complexes (-3122 to -3264 p.p.m.; Tessier & Rochon, 1999). The reaction of compound (I) with silver nitrate in acetone (Souchard et al., 1990; Tessier & Rochon, 2001) results in the formation of the trans-Pt(3-Acpy)2(NO3)2 species, as indicated by the 195Pt NMR signal (CDCl3) observed at -1474 p.p.m. The expected values for trans-Pt(Ypy)2(NO3)2 are from -1402 to -1481 p.p.m. (Tessier & Rochon, 2001).

Computing details top

Data collection: XSCANS (Siemens, 1995); cell refinement: XSCANS; data reduction: XSCANS; program(s) used to solve structure: SHELXS97 (Sheldrick, 1997); program(s) used to refine structure: SHELXL97 (Sheldrick, 1997); molecular graphics: SHELXTL (Bruker, 2003); software used to prepare material for publication: SHELXTL.

Figures top
[Figure 1] Fig. 1. A diagram of compound (I) with the atom-labeling scheme. Displacement ellipsoids are drawn at the 50% probability level.
trans-Bis(3-acetylpyridine-κN)diiodoplatinum(II) top
Crystal data top
[PtI2(C7H7NO)2]F(000) = 624
Mr = 691.16Dx = 2.652 Mg m3
Monoclinic, P21/cMo Kα radiation, λ = 0.71073 Å
Hall symbol: -P 2ybcCell parameters from 22 reflections
a = 4.632 (1) Åθ = 2.2–13.6°
b = 16.456 (5) ŵ = 11.68 mm1
c = 11.483 (3) ÅT = 292 K
β = 98.57 (3)°Platelet, yellow
V = 865.5 (4) Å30.31 × 0.10 × 0.04 mm
Z = 2
Data collection top
Siemens P4
diffractometer
1494 reflections with I > 2σ(I)
Radiation source: fine-focus sealed tubeRint = 0.028
Graphite monochromatorθmax = 27.5°, θmin = 2.2°
2θ/ω scansh = 60
Absorption correction: integration
(XPREP; Bruker, 2003)
k = 210
Tmin = 0.313, Tmax = 0.631l = 1414
2206 measured reflections3 standard reflections every 97 reflections
1970 independent reflections intensity decay: none
Refinement top
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.035Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.078H-atom parameters constrained
S = 1.00 w = 1/[σ2(Fo2) + (0.0276P)2]
where P = (Fo2 + 2Fc2)/3
1970 reflections(Δ/σ)max < 0.001
98 parametersΔρmax = 0.87 e Å3
0 restraintsΔρmin = 0.78 e Å3
Crystal data top
[PtI2(C7H7NO)2]V = 865.5 (4) Å3
Mr = 691.16Z = 2
Monoclinic, P21/cMo Kα radiation
a = 4.632 (1) ŵ = 11.68 mm1
b = 16.456 (5) ÅT = 292 K
c = 11.483 (3) Å0.31 × 0.10 × 0.04 mm
β = 98.57 (3)°
Data collection top
Siemens P4
diffractometer
1494 reflections with I > 2σ(I)
Absorption correction: integration
(XPREP; Bruker, 2003)
Rint = 0.028
Tmin = 0.313, Tmax = 0.6313 standard reflections every 97 reflections
2206 measured reflections intensity decay: none
1970 independent reflections
Refinement top
R[F2 > 2σ(F2)] = 0.0350 restraints
wR(F2) = 0.078H-atom parameters constrained
S = 1.00Δρmax = 0.87 e Å3
1970 reflectionsΔρmin = 0.78 e Å3
98 parameters
Special details top

Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.

Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) top
xyzUiso*/Ueq
Pt10.00000.00000.00000.03634 (12)
I10.33217 (12)0.04824 (3)0.19118 (4)0.04814 (15)
N10.0164 (14)0.1154 (4)0.0620 (5)0.0384 (13)
O10.4735 (16)0.2958 (4)0.0833 (6)0.0726 (19)
C20.1508 (16)0.1749 (4)0.0096 (6)0.0383 (16)
H20.24630.16140.05340.046*
C30.1527 (15)0.2547 (4)0.0453 (6)0.0351 (15)
C40.0141 (17)0.2749 (5)0.1416 (6)0.0424 (17)
H40.01080.32830.16820.051*
C50.1182 (18)0.2130 (5)0.1962 (7)0.0491 (19)
H50.20770.22440.26160.059*
C60.1179 (17)0.1358 (5)0.1545 (6)0.0439 (17)
H60.21350.09550.19090.053*
C70.2979 (18)0.3172 (5)0.0218 (6)0.0457 (18)
C80.213 (2)0.4039 (5)0.0139 (8)0.065 (2)
H8A0.36770.43800.03250.098*
H8B0.03890.41420.06860.098*
H8C0.17690.41550.06460.098*
Atomic displacement parameters (Å2) top
U11U22U33U12U13U23
Pt10.0495 (2)0.02541 (17)0.03624 (19)0.0038 (2)0.01324 (15)0.00082 (17)
I10.0585 (3)0.0408 (3)0.0453 (3)0.0025 (3)0.0083 (2)0.0036 (2)
N10.047 (3)0.032 (3)0.037 (3)0.003 (3)0.008 (3)0.003 (2)
O10.079 (5)0.063 (4)0.083 (4)0.001 (4)0.037 (4)0.016 (4)
C20.041 (4)0.032 (4)0.042 (4)0.005 (3)0.007 (3)0.007 (3)
C30.040 (4)0.032 (3)0.035 (3)0.003 (3)0.009 (3)0.000 (3)
C40.049 (4)0.036 (4)0.044 (4)0.006 (4)0.011 (3)0.005 (3)
C50.059 (5)0.049 (5)0.044 (4)0.000 (4)0.021 (4)0.007 (4)
C60.050 (4)0.044 (4)0.040 (4)0.008 (4)0.014 (3)0.001 (3)
C70.061 (5)0.038 (4)0.041 (4)0.004 (4)0.015 (4)0.001 (3)
C80.095 (7)0.037 (4)0.065 (5)0.009 (5)0.016 (5)0.001 (4)
Geometric parameters (Å, º) top
Pt1—N12.026 (6)C4—C51.386 (11)
Pt1—I12.6097 (10)C4—H40.9300
N1—C21.349 (9)C5—C61.358 (11)
N1—C61.351 (9)C5—H50.9300
O1—C71.206 (9)C6—H60.9300
C2—C31.375 (10)C7—C81.486 (11)
C2—H20.9300C8—H8A0.9600
C3—C41.400 (9)C8—H8B0.9600
C3—C71.503 (10)C8—H8C0.9600
N1—Pt1—I190.19 (17)C6—C5—H5119.8
N1—Pt1—I1i89.81 (17)C4—C5—H5119.8
C2—N1—C6117.9 (6)N1—C6—C5122.3 (7)
C2—N1—Pt1121.3 (5)N1—C6—H6118.9
C6—N1—Pt1120.7 (5)C5—C6—H6118.9
N1—C2—C3122.9 (6)O1—C7—C8121.6 (8)
N1—C2—H2118.5O1—C7—C3119.5 (7)
C3—C2—H2118.5C8—C7—C3118.8 (7)
C2—C3—C4118.6 (7)C7—C8—H8A109.5
C2—C3—C7119.0 (6)C7—C8—H8B109.5
C4—C3—C7122.4 (7)H8A—C8—H8B109.5
C5—C4—C3117.9 (7)C7—C8—H8C109.5
C5—C4—H4121.0H8A—C8—H8C109.5
C3—C4—H4121.0H8B—C8—H8C109.5
C6—C5—C4120.3 (7)
I1—Pt1—N1—C2113.5 (5)C7—C3—C4—C5178.8 (7)
I1i—Pt1—N1—C266.5 (5)C3—C4—C5—C61.6 (12)
I1—Pt1—N1—C669.2 (6)C2—N1—C6—C50.8 (11)
I1i—Pt1—N1—C6110.8 (6)Pt1—N1—C6—C5178.1 (6)
C6—N1—C2—C30.9 (11)C4—C5—C6—N12.1 (13)
Pt1—N1—C2—C3176.4 (5)C2—C3—C7—O119.7 (11)
N1—C2—C3—C41.3 (11)C4—C3—C7—O1161.5 (8)
N1—C2—C3—C7177.5 (7)C2—C3—C7—C8158.1 (8)
C2—C3—C4—C50.0 (11)C4—C3—C7—C820.6 (11)
Symmetry code: (i) x, y, z.

Experimental details

Crystal data
Chemical formula[PtI2(C7H7NO)2]
Mr691.16
Crystal system, space groupMonoclinic, P21/c
Temperature (K)292
a, b, c (Å)4.632 (1), 16.456 (5), 11.483 (3)
β (°) 98.57 (3)
V3)865.5 (4)
Z2
Radiation typeMo Kα
µ (mm1)11.68
Crystal size (mm)0.31 × 0.10 × 0.04
Data collection
DiffractometerSiemens P4
Absorption correctionIntegration
(XPREP; Bruker, 2003)
Tmin, Tmax0.313, 0.631
No. of measured, independent and
observed [I > 2σ(I)] reflections
2206, 1970, 1494
Rint0.028
(sin θ/λ)max1)0.649
Refinement
R[F2 > 2σ(F2)], wR(F2), S 0.035, 0.078, 1.00
No. of reflections1970
No. of parameters98
H-atom treatmentH-atom parameters constrained
Δρmax, Δρmin (e Å3)0.87, 0.78

Computer programs: XSCANS (Siemens, 1995), XSCANS, SHELXS97 (Sheldrick, 1997), SHELXL97 (Sheldrick, 1997), SHELXTL (Bruker, 2003), SHELXTL.

Selected geometric parameters (Å, º) top
Pt1—N12.026 (6)C3—C71.503 (10)
Pt1—I12.6097 (10)C7—C81.486 (11)
O1—C71.206 (9)
N1—Pt1—I190.19 (17)O1—C7—C3119.5 (7)
N1—Pt1—I1i89.81 (17)C8—C7—C3118.8 (7)
O1—C7—C8121.6 (8)
C2—C3—C7—O119.7 (11)C2—C3—C7—C8158.1 (8)
C4—C3—C7—O1161.5 (8)C4—C3—C7—C820.6 (11)
Symmetry code: (i) x, y, z.
Bond distances (Å) and dihedral angles (°) for the literature trans-Pt(Ypy)2I2 complexes top
CSD refcodeYpyPt—NPt—IDihedral angleReference
KARVEE2-Mepy2.0242.61481.9(a)
2.0552.61689.9(a)
DIPYPTPy2.0352.59774.0(b)
KARTUS4-Mepy2.0172.60370.4(a)
ACAZOU3-(NHSO2Me)py2.0322.60769.1(c)
KARVAA3-Mepy2.0202.60463.5(a)
References: (a) Tessier & Rochon (1999). (b) Thiele & Wagner (1978). (c) Dodoff et al. (2004).
Dihedral angles (°) between the pyridine derivative rings and the planes formed by the –C–C(O)–R atoms in square-planar platinum complexes containing
at least one C(O)R-pyridine derivative
top
CSD refcodeCompoundDihedral angleReference
MUYBEN[Pt(4-(COOH)py)(Ph2MeP)2(Ph)](OTf)3.9(a)
MUYBIR[Pt(4-(COOH)py)(PEt3)2(Ph)](OTf)11.4(a)
TEXFEH[Pt(4-(COOH)py)(2,6-(MeMet)py)](ClO4)a5.6(b)
XURDIXPt(3-(COO)2-hypy)(PPh3)2Clb1.9(c)
FOQXAKPt(2-(COO)3-hypy)(PPh3)2Clc3.7(d)
CLPRPTtrans-Pt(4-(COOEt)py)2Cl21.2(e)
NIXMIQtrans-Pt(3-(CONHR)py)2Cl2d33.4(f)
XIKJEGcis-[Pt(4-(CONH2)py)2(PEt3)2](NO3)221.0; 33.5(g)
JOSDAW01cis-[Pt(4-(CONH2)py)2(NH3)2](NO3)225.7(h)
GOKMOIPt(4-(COO)py)2(4-(COOH)py)23.2-21.0(i)
GOKMIC[Pt(4-(CONH2)py)4]Cl2e12.0; 21.8(i)
XAYKUD[Pt(4-(CONH2)py)4]Cl2f33.9(j)
XAYLAK[Pt(4-(CONH2)py)4](PF6)27.6-38.4(j)
JOQSOX[Pt(3-(CONH2)py)4]Cl220.0; 40.4(k)
JOQSUD[Pt(3-(CONH2)py)4](PF6)21.8; 8.4(k)
QEXLAG[Pt(3-(CONHBu)py)4](PF6)214.0(l)
QEXLEK[Pt(3-(CONHBu)py)4](ReO4)219.2(l)
a2,6-(MeMet)py = 2,6-bis(methylthiomethyl)pyridine. b3-(COO)2-hypy = 2-hydroxynicotinate. c2-(COO)3-hypy = 3-hydroxypicolinato. d3-(CONHR)py = N-nitroxyethylnicotinamide. etetrakis(4-aldoximepyridine)clathrate. f = heptahydrate. References: (a) Crisp et al. (2003). (b) Marangoni et al. (1996). (c) Quintal et al. (2002). (d) Quintal et al. (2000). (e) Camalli et al. (1980). (f) Eremenko et al. (1997). (g) Kuehl et al. (2001). (h) Minacheva et al. (1991). (i) Aakeroy et al. (1999). (j) Brammer et al. (2000). (k) Mareque Rivas & Brammer (1998). (l) Bondy et al. (2001).
 

Subscribe to Acta Crystallographica Section C: Structural Chemistry

The full text of this article is available to subscribers to the journal.

If you have already registered and are using a computer listed in your registration details, please email support@iucr.org for assistance.

Buy online

You may purchase this article in PDF and/or HTML formats. For purchasers in the European Community who do not have a VAT number, VAT will be added at the local rate. Payments to the IUCr are handled by WorldPay, who will accept payment by credit card in several currencies. To purchase the article, please complete the form below (fields marked * are required), and then click on `Continue'.
E-mail address* 
Repeat e-mail address* 
(for error checking) 

Format*   PDF (US $40)
   HTML (US $40)
   PDF+HTML (US $50)
In order for VAT to be shown for your country javascript needs to be enabled.

VAT number 
(non-UK EC countries only) 
Country* 
 

Terms and conditions of use
Contact us

Follow Acta Cryst. C
Sign up for e-alerts
Follow Acta Cryst. on Twitter
Follow us on facebook
Sign up for RSS feeds